WEST SACRAMENTO, Calif., September 23, 2003 - Lipomics Technologies Inc., a privately owned company that specializes in lipid metabolite research, today announced the appointment of Rosemary L. Walzem, Ph.D., as the company's first Visiting Scientist.
Dr. Walzem is Associate Professor of Nutritional Biochemistry at Texas A&M University.
research involves studying the structure of lipoproteins and identifying mechanisms and regulatory processes that control the assembly of triglyceride-rich lipoproteins in tissues.
While working with Lipomics, Dr. Walzem intends to deepen her understanding of high-dimensional lipid data sets as a tool for assessing lipid metabolism.
measures up to 500 lipid metabolites in a single sample," said Dr. Walzem